ANGIODYNAMICS INC — Director's Dealing 2016

Jul 29, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-07-27

Reporting Person: Trowbridge Stephen A (SVP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-27	Common Stock	A	3447	—	Acquired	31280	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-27	Non-Qualified Stock Option (right to buy)	$16.59	A	12142	Acquired	2023-07-27	Common Stock (12142)	Direct
2016-07-27	Performance Right	$	A	6894	Acquired		Common Stock (6894)	Direct

Footnotes

F1: This acquisition of 3,447 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 3,447 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 27,2017, such that 25% of the restricted stock units will vest on each of July 27, 2017, 2018, 2019 and 2020.

F2: These stock options vest in four equal annual installments beginning on July 27, 2017, such that 25% of the options will vest on each of July 27, 2017, 2018, 2019 and 2020.

F3: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2017, 2018 and 2019. Any shares that do not vest at the end of the performance period will be forfeited.